Researchers from Bonn and Erlangen identify the protein MLC1 as a target antigen in multiple sclerosis (MS); a chronic ...

VIVOZON Pharmaceutical announced that its non-opioid analgesic, UNAFRA Inj., was approved on December 12, 2024.

Researchers at Jilin University (Changchun, China) developed a highly sensitive, rapid, and accurate method for analyzing ...

Nura Bio, Inc. (Nura Bio), a clinical-stage, biopharmaceutical company developing neuroprotective, small molecule therapies for the treatment of debilitating neurological diseases, announced today the ...

< Under the microscope: In the brain section of an MS patient, the neurons are shown in green and the ... University Hospital Bonn (UKB) / Research group Prof. Stefanie Kürten ...

Equities research analysts at B. Riley issued their FY2029 earnings per share estimates for Trevi Therapeutics in a research ...

The Facial Pain Association Trigeminal Neuralgia Support Group of Central Indiana will have a meeting on Saturday, Feb. 22, ...

US pharma giant Merck & Co today announced that the European Commission (EC) has conditionally approved two indications for Welireg (belzutifan), its oral hypoxia-inducible factor-2 alpha (HIF-2α) ...

The rapid rise of artificial intelligence (AI) across numerous sectors of the economy has garnered the attention of state attorneys general (AGs).